The report provides market dynamics and trends related to the global irritable bowel syndrome treatment market. In addition, it presents the estimations and forecast of the market. The study estimates the revenue generated from the sales of irritable bowel syndrome treatment drugs; however, it excludes the irritable bowel syndrome treatment service revenue. The valuations comprise revenue generated from irritable bowel syndrome treatment drug type such as rifaximin, eluxadoline, lubiprostone, linaclotide, and others that are used for the treatment of irritable bowel syndrome. Furthermore, the report excludes revenue generated from post- sale services of irritable bowel syndrome treatment drugs.

INTRODUCTION 

EXECUTIVE SUMMARY 

MARKET OVERVIEW 

IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY TYPE

IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY PRODUCT 

IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL 

IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY REGION 

COMPANY PROFILES